Miyoshi Sakai

ShinEtsu Chemical (Japan)

Papers

1

Total Citations

42

H-Index

1

About

Miyoshi Sakai is a leading figure in the field of minimally invasive gastric cancer surgery, with a focused expertise in robotic and laparoscopic gastrectomy. His most-cited work, a multi-institutional retrospective study from 2022, directly compares three-year outcomes of robotic versus laparoscopic gastrectomy for clinical stage I/II gastric cancer, amassing 42 citations. This research provides critical, long-term evidence on the efficacy and safety of robotic approaches, helping to define best practices in surgical oncology. By rigorously evaluating survival and complication rates, Sakai’s contributions have advanced the adoption of robotic techniques, offering patients potentially less invasive options with comparable oncologic outcomes. His work is particularly influential for surgeons and researchers seeking to optimize treatment pathways for early-stage gastric cancer, bridging the gap between technological innovation and clinical application. Through these efforts, Sakai has established himself as a key voice in the evolution of gastric cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
42
Total Citations
42
Avg Citations/Paper
🏆 Most Cited Paper
Three-year outcomes of robotic gastrectomy versus laparoscopic gastrectomy for the treatment of clinical stage I/II gastric cancer: a multi-institutional retrospective comparative study
42 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: ShinEtsu Chemical (Japan)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago